The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Acemetacin (CAS 53164-05-9) is a carboxylic ester that is the carboxymethyl ester of indometacin. A non-steroidal anti-inflammatory drug, it is used in the treatment of rheumatoid arthritis, osteoarthritis, and low back pain, as well as for postoperative pain and inflammation.
The global Acemetacin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Acemetacin has proven effective in the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and other kinds of rheumatoid inflammation, as well as in post-operative and post-traumatic pain and attack of gout.
This report aims to provide a comprehensive presentation of the global market for Acemetacin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acemetacin.
Report Scope
The Acemetacin market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acemetacin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acemetacin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
3B Scientific
CSPC
DC Chemicals
OChem
Adooq BioScience
Clearsynth
Angene Chemical
Vlada Chem
AbMole Bioscience
MuseChem
AHH Chemical
Jiangmin Taihua Chemical
Segment by Type
98% Purity Type
99% Purity Type
Others
Segment by Application
Asimicin Capsule (30mg)
Asimexin Sustained Release Capsule (90mg)
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Acemetacin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Acemetacin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Acemetacin (CAS 53164-05-9) is a carboxylic ester that is the carboxymethyl ester of indometacin. A non-steroidal anti-inflammatory drug, it is used in the treatment of rheumatoid arthritis, osteoarthritis, and low back pain, as well as for postoperative pain and inflammation.
The global Acemetacin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Acemetacin has proven effective in the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and other kinds of rheumatoid inflammation, as well as in post-operative and post-traumatic pain and attack of gout.
This report aims to provide a comprehensive presentation of the global market for Acemetacin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acemetacin.
Report Scope
The Acemetacin market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acemetacin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acemetacin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
3B Scientific
CSPC
DC Chemicals
OChem
Adooq BioScience
Clearsynth
Angene Chemical
Vlada Chem
AbMole Bioscience
MuseChem
AHH Chemical
Jiangmin Taihua Chemical
Segment by Type
98% Purity Type
99% Purity Type
Others
Segment by Application
Asimicin Capsule (30mg)
Asimexin Sustained Release Capsule (90mg)
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Acemetacin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Acemetacin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Acemetacin Market Overview
1.1 Product Overview and Scope of Acemetacin
1.2 Acemetacin Segment by Type
1.2.1 Global Acemetacin Market Value Comparison by Type (2024-2030)
1.2.2 98% Purity Type
1.2.3 99% Purity Type
1.2.4 Others
1.3 Acemetacin Segment by Application
1.3.1 Global Acemetacin Market Value by Application: (2024-2030)
1.3.2 Asimicin Capsule (30mg)
1.3.3 Asimexin Sustained Release Capsule (90mg)
1.4 Global Acemetacin Market Size Estimates and Forecasts
1.4.1 Global Acemetacin Revenue 2019-2030
1.4.2 Global Acemetacin Sales 2019-2030
1.4.3 Global Acemetacin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Acemetacin Market Competition by Manufacturers
2.1 Global Acemetacin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Acemetacin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Acemetacin Average Price by Manufacturers (2019-2024)
2.4 Global Acemetacin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Acemetacin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Acemetacin, Product Type & Application
2.7 Acemetacin Market Competitive Situation and Trends
2.7.1 Acemetacin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Acemetacin Players Market Share by Revenue
2.7.3 Global Acemetacin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Acemetacin Retrospective Market Scenario by Region
3.1 Global Acemetacin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Acemetacin Global Acemetacin Sales by Region: 2019-2030
3.2.1 Global Acemetacin Sales by Region: 2019-2024
3.2.2 Global Acemetacin Sales by Region: 2025-2030
3.3 Global Acemetacin Global Acemetacin Revenue by Region: 2019-2030
3.3.1 Global Acemetacin Revenue by Region: 2019-2024
3.3.2 Global Acemetacin Revenue by Region: 2025-2030
3.4 North America Acemetacin Market Facts & Figures by Country
3.4.1 North America Acemetacin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Acemetacin Sales by Country (2019-2030)
3.4.3 North America Acemetacin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Acemetacin Market Facts & Figures by Country
3.5.1 Europe Acemetacin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Acemetacin Sales by Country (2019-2030)
3.5.3 Europe Acemetacin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Acemetacin Market Facts & Figures by Country
3.6.1 Asia Pacific Acemetacin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Acemetacin Sales by Country (2019-2030)
3.6.3 Asia Pacific Acemetacin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Acemetacin Market Facts & Figures by Country
3.7.1 Latin America Acemetacin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Acemetacin Sales by Country (2019-2030)
3.7.3 Latin America Acemetacin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Acemetacin Market Facts & Figures by Country
3.8.1 Middle East and Africa Acemetacin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Acemetacin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Acemetacin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Acemetacin Sales by Type (2019-2030)
4.1.1 Global Acemetacin Sales by Type (2019-2024)
4.1.2 Global Acemetacin Sales by Type (2025-2030)
4.1.3 Global Acemetacin Sales Market Share by Type (2019-2030)
4.2 Global Acemetacin Revenue by Type (2019-2030)
4.2.1 Global Acemetacin Revenue by Type (2019-2024)
4.2.2 Global Acemetacin Revenue by Type (2025-2030)
4.2.3 Global Acemetacin Revenue Market Share by Type (2019-2030)
4.3 Global Acemetacin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Acemetacin Sales by Application (2019-2030)
5.1.1 Global Acemetacin Sales by Application (2019-2024)
5.1.2 Global Acemetacin Sales by Application (2025-2030)
5.1.3 Global Acemetacin Sales Market Share by Application (2019-2030)
5.2 Global Acemetacin Revenue by Application (2019-2030)
5.2.1 Global Acemetacin Revenue by Application (2019-2024)
5.2.2 Global Acemetacin Revenue by Application (2025-2030)
5.2.3 Global Acemetacin Revenue Market Share by Application (2019-2030)
5.3 Global Acemetacin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 3B Scientific
6.1.1 3B Scientific Corporation Information
6.1.2 3B Scientific Description and Business Overview
6.1.3 3B Scientific Acemetacin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 3B Scientific Acemetacin Product Portfolio
6.1.5 3B Scientific Recent Developments/Updates
6.2 CSPC
6.2.1 CSPC Corporation Information
6.2.2 CSPC Description and Business Overview
6.2.3 CSPC Acemetacin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSPC Acemetacin Product Portfolio
6.2.5 CSPC Recent Developments/Updates
6.3 DC Chemicals
6.3.1 DC Chemicals Corporation Information
6.3.2 DC Chemicals Description and Business Overview
6.3.3 DC Chemicals Acemetacin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 DC Chemicals Acemetacin Product Portfolio
6.3.5 DC Chemicals Recent Developments/Updates
6.4 OChem
6.4.1 OChem Corporation Information
6.4.2 OChem Description and Business Overview
6.4.3 OChem Acemetacin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 OChem Acemetacin Product Portfolio
6.4.5 OChem Recent Developments/Updates
6.5 Adooq BioScience
6.5.1 Adooq BioScience Corporation Information
6.5.2 Adooq BioScience Description and Business Overview
6.5.3 Adooq BioScience Acemetacin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Adooq BioScience Acemetacin Product Portfolio
6.5.5 Adooq BioScience Recent Developments/Updates
6.6 Clearsynth
6.6.1 Clearsynth Corporation Information
6.6.2 Clearsynth Description and Business Overview
6.6.3 Clearsynth Acemetacin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Clearsynth Acemetacin Product Portfolio
6.6.5 Clearsynth Recent Developments/Updates
6.7 Angene Chemical
6.6.1 Angene Chemical Corporation Information
6.6.2 Angene Chemical Description and Business Overview
6.6.3 Angene Chemical Acemetacin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Angene Chemical Acemetacin Product Portfolio
6.7.5 Angene Chemical Recent Developments/Updates
6.8 Vlada Chem
6.8.1 Vlada Chem Corporation Information
6.8.2 Vlada Chem Description and Business Overview
6.8.3 Vlada Chem Acemetacin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Vlada Chem Acemetacin Product Portfolio
6.8.5 Vlada Chem Recent Developments/Updates
6.9 AbMole Bioscience
6.9.1 AbMole Bioscience Corporation Information
6.9.2 AbMole Bioscience Description and Business Overview
6.9.3 AbMole Bioscience Acemetacin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AbMole Bioscience Acemetacin Product Portfolio
6.9.5 AbMole Bioscience Recent Developments/Updates
6.10 MuseChem
6.10.1 MuseChem Corporation Information
6.10.2 MuseChem Description and Business Overview
6.10.3 MuseChem Acemetacin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 MuseChem Acemetacin Product Portfolio
6.10.5 MuseChem Recent Developments/Updates
6.11 AHH Chemical
6.11.1 AHH Chemical Corporation Information
6.11.2 AHH Chemical Acemetacin Description and Business Overview
6.11.3 AHH Chemical Acemetacin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 AHH Chemical Acemetacin Product Portfolio
6.11.5 AHH Chemical Recent Developments/Updates
6.12 Jiangmin Taihua Chemical
6.12.1 Jiangmin Taihua Chemical Corporation Information
6.12.2 Jiangmin Taihua Chemical Acemetacin Description and Business Overview
6.12.3 Jiangmin Taihua Chemical Acemetacin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Jiangmin Taihua Chemical Acemetacin Product Portfolio
6.12.5 Jiangmin Taihua Chemical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Acemetacin Industry Chain Analysis
7.2 Acemetacin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Acemetacin Production Mode & Process
7.4 Acemetacin Sales and Marketing
7.4.1 Acemetacin Sales Channels
7.4.2 Acemetacin Distributors
7.5 Acemetacin Customers
8 Acemetacin Market Dynamics
8.1 Acemetacin Industry Trends
8.2 Acemetacin Market Drivers
8.3 Acemetacin Market Challenges
8.4 Acemetacin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
